# MIDDAY Agentic Swing Scan — 2026-08-10

- Timestamp: 2026-08-10 16:00–16:03 UTC / 12:00–12:03 ET
- Account: Robinhood Agentic 433711041 / ending 1041 only
- Policy: ACTIVE; autonomous, long fractional equities only
- Decision: **HOLD all five positions; no new order, exit, trim, cancellation, preview, or placement.**

## Broker and safety verification

- Account verified active cash account, nickname Agentic, `agentic_allowed=true`; no other account operated.
- Portfolio: $336.70999 total, $330.49999 equity, $6.21 cash/buying power; no pending deposits or unsettled funds.
- Positions: AVGO 0.095750 @ $411.28; MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12; SHOP 0.862075 @ $144.09; NESR 0.736516 @ $33.74.
- Open-ish equity states checked independently: new, queued, confirmed, unconfirmed, partially_filled — all empty. Pending-order commitment $0.
- Today's only fill: NESR buy order `6a79d7bc-78ff-4efa-87d5-ad2434cf8c2e`, 0.736516 shares / $24.85 at average $33.7399, filled 13:53:00 UTC, $0 fees.
- Kill switches clear: account value >$10; total value is +0.38% versus post-open fill verification (~$335.43) and no 5% daily/10% peak drawdown gate is triggered. Live broker/account/risk state was coherent for management.

## Midday regime and sector flow

- SPY $774.23 (+0.13%), QQQ $723.45 (+0.06%), IWM $300.07 (-0.49%): large-cap indexes held near highs but small caps lagged.
- XLE +3.36% was the decisive leader; XLF +0.37% also outperformed. SMH -0.90%, XLK -0.01%, XLY -0.07% showed selective rotation away from semiconductors/growth beta rather than broad liquidation.
- CPI (Aug. 12), PPI (Aug. 13), and retail sales (Aug. 14) remain near-term macro risks; avoid chasing extended gaps before those releases.

## Holding reassessment

| Symbol | Midday | P/L vs entry | Structure / context | Binding stop | Targets | Decision |
|---|---:|---:|---|---:|---:|---|
| AVGO | $427.155 | +3.86% / +$1.52 | Above SMA10 $398.86 and SMA20 $391.86; rejected from $432.73 intraday but remains near breakout resistance. SMH lagged, so no add. AI revenue growth remains strong; ~65x P/E is valuation risk. | $410.00 | $440/$455 | Hold |
| MA | $563.075 | -1.64% / -$1.07 | Below SMA10 $567.97 but above SMA20 $553.67; weakest relative-strength holding, though no $550 invalidation. High-margin payments franchise remains fundamentally sound. | $550.00 | $584/$600 | Hold/watch; first rotation candidate |
| BAC | $63.725 | +2.58% / +$1.68 | Above SMA10 $62.43 and SMA20 $61.77, testing $64 52-week resistance with XLF positive. Q2 revenue/net-income improvement supports thesis. | $61.40 | $64.80/$66 | Hold |
| SHOP | $154.90 | +7.50% / +$9.31 | New 20-day breakout above prior $153.88; intraday range $148.90–$155.44. Strong earnings/guidance support, but very extended from SMA10 $130.94 and ~115x P/E; no add. | $143.50 | $160/$165 | Hold |
| NESR | $34.39 | +1.93% / +$0.48 | Earnings gap held above entry; intraday $31.86–$34.84 and XLE +3.36%. Q2 revenue +59.1% YoY, EPS beat, stronger OCF and lower net debt support catalyst. Stop remains opening-low thesis level and was not widened. | $31.85 | $36.60/$38 | Hold |

Approximate planned risk to binding stops is ~$5.68, within the ~$6 default aggregate guide. No stop was widened and no losing position was added to.

## Broad ranked opportunities

1. **NESR 8.8/10 — already held.** Best combination of direct earnings catalyst, oilfield-services fundamentals, energy-sector inflow and clear $31.85 invalidation. Do not add after the gap without a new planned scale-in.
2. **FSLY 7.4/10 — watch retest.** $27.075, +17.9%, liquid (~6.9M average volume), above SMA10/20, but gap is extended and company remains loss-making. Require a controlled retest near $25.50–$26; stop ~$24.40; targets $29/$31. No chase.
3. **ABCL 7.2/10 — watch only.** $9.225, +33.1%, ~2.4x normal full-day volume by noon and breakout above prior $6.99, but loss-making biotech and weak recent earnings create catalyst-quality risk. Require stable $9.00–$9.20 retest; stop $8.39; targets $11/$12.
4. **ACHR 6.9/10 — event-risk watch.** $6.31, +12.9%, highly liquid, but faded from $6.87 and earnings are after close; pre-revenue/loss profile makes pre-event entry unsuitable. Reassess only after results.
5. **MA 6.7/10 — current hold, not a new buy.** Clean stop and quality fundamentals, but relative strength trails BAC/NESR/SHOP; rotate only on $550 failure or materially superior confirmed setup.

VREX, HZO and BWMN were rejected despite large moves: acquisition/deal-gap asymmetry or extreme extension made normal swing reward/risk unattractive. Microcap scanner leaders were rejected for price, market-cap, spread, or catalyst-quality concerns.

## Deployment and action

- Liquid buying power after pending orders: $6.21.
- Mechanical 80/20 split of that balance: $4.97 deploy / $1.24 reserve.
- Actual new deployment: $0.00. The $6.21 is the 19.99% reserve deliberately retained from the $31.06 post-open liquid pool after the $24.85 NESR purchase. Recursively spending 80% of the reserve would defeat the same-scan cash-buffer rule; additionally, the account already has five positions (above the policy's preferred 1–4) and no candidate justified churn or a sixth holding.
- Total marked equity deployment: $330.50 / $336.71 = 98.16%; cash = 1.84% of account value. Relative to the post-open $31.06 liquid decision pool, $24.85 (80.01%) is deployed and $6.21 (19.99%) remains reserved.
- No order qualified for review, so policy correctly produced no placement. Power-hour priorities: watch MA $550, SHOP $148.80 intraday/$143.50 swing, NESR $31.85, and avoid carrying unjustified new event risk into CPI week.

## Tool/source notes

- Robinhood MCP connected with 54 tools. Account, portfolio, position, five-state order, fill, scanner, quote, daily/intraday OHLCV, and fundamentals calls ultimately returned usable live data.
- Initial batched historical/tradability requests exceeded the 10-symbol tool limit; they were retried in compliant batches. A fundamentals call temporarily hit the MCP three-failure circuit breaker; after cooldown it succeeded symbol-by-symbol. These research-path failures did not create unresolved broker/account uncertainty, and no order action depended on incomplete data.
- The earnings-calendar probe rejected an unsupported `end_date` parameter; existing morning verified earnings context and current web/news checks were used instead. No claims of guaranteed returns are made.
